Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Bartonella infections: diverse and elusive

¹Department of Medicine, Stanford University School of Medicine, Calif., USA.

Hospital Practice (1995)

|December 29, 1998

Summary

Bartonella infections pose risks to immunocompromised individuals and children with cats. Treatment varies, with supportive care for cat-scratch disease and macrolides for other Bartonella infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.

Antimicrobial agents and chemotherapy·2022

Same author

Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients.

Antimicrobial agents and chemotherapy·2021

Same author

Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults.

Pulmonary pharmacology & therapeutics·2009

Same author

Pneumocephalus due to invasive fungal sinusitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000

Same author

Lemierre's syndrome.

Southern medical journal·1997

Same author

Bartonella infections.

Current clinical topics in infectious diseases·1997

Area of Science:

Microbiology
Infectious Diseases
Public Health

Background:

Bartonella species are increasingly recognized as significant human pathogens.
Understanding the diverse clinical manifestations and risk factors is crucial for effective management.

Observation:

Specific populations, including children with young cats, HIV patients with low CD4 counts, and homeless individuals with lice, exhibit heightened susceptibility.
Clinical presentation of Bartonella infections is highly variable, depending on the specific Bartonella species and host immune status.

Findings:

Cat-scratch disease management is primarily supportive.
Macrolide antibiotics represent an effective therapeutic option for other systemic Bartonella infections.

Implications:

Early identification of at-risk individuals and prompt, appropriate treatment are essential for mitigating Bartonella-related morbidity.
Further research into Bartonella pathogenesis and novel therapeutic strategies is warranted.

Related Experiment Videos